Synapsoft logo
AI Insights from Disclosures
Searching...
DAE HWA PHARM CO., LTD 067080
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
DAE HWA PHARM CO., LTD operates its No. 1 plant, which produces solid formulations certified under GMP (Good Manufacturing Practice) standards by the Ministry of Food and Drug Safety, its No. 2 plant, which produces transdermal preparations, and its No. 3 plant, which produces anticancer drugs, while its main subsidiary, Redox Bio Co., Ltd., manufactures hyaluronic acid (HA) and chemicals. The company operates through the pharmaceutical manufacturing segment, pharmaceutical wholesale segment, medical information system segment, pharmaceutical raw material manufacturing and sales segment, and cosmetics and medical device manufacturing and sales segment.
Representative Director 김은석(단독대표)
Founded January 19, 1989
Corporation Type KOSDAQ
Industry Classification Manufacture of medicaments
Corporate number 21111-0001529
Business number 133-81-22322
Phone Number 02-586-6451
Fax Number 02)587-0566
Company Address 495 Hanu-ro, Hoengseong-eup, Hoengseong-gun, Gangwon-do
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant